Inventor · disambiguated record
Adam J. Morgan
Also filed as: MORGAN ADAM · MORGAN ADAM J
29 granted patents·32 pending applications·391 citations·filing 2002–2025
97Inventor score
Files withCONCERT PHARMACEUTICALS INC21SUN PHARMACEUTICAL IND INC7VERTEX PHARMACEUTICALS EUROPE LTD6CARDIAC PACEMAKERS INC5TARGET BRANDS INC4
Top patents by PatentIndex Score
61 records- 0199US9512079B2Deuterated CFTR potentiatorsCONCERT PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·39 cites·15 claims
- 0299US9181192B2Deuterated CFTR potentiatorsCONCERT PHARMACEUTICALS INC·Filed 2014·Granted Nov 10, 2015·43 cites·18 claims
- 0398US9249149B2Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2015·Granted Feb 2, 2016·62 cites·15 claims
- 0498US8759394B24-hydroxybutyric acid analogsTUNG ROGER D·Filed 2012·Granted Jun 24, 2014·72 cites·4 claims
- 0597US10047053B2Deuterated CFTR potentiatorsVERTEX PHARMACEUTICALS EUROPE LTD·Filed 2017·Granted Aug 14, 2018·11 cites·20 claims
- 0697US8865902B2Deuterated CFTR potentiatorsMORGAN ADAM J·Filed 2013·Granted Oct 21, 2014·68 cites·13 claims
- 0796US10479766B2Deuterated CFTR potentiatorsVERTEX PHARMACEUTICALS EUROPE LTD·Filed 2018·Granted Nov 19, 2019·8 cites·20 claims
- 0896US9309182B24-hydroxybutyric acid analogsCONCERT PHARMACEUTICALS INC·Filed 2014·Granted Apr 12, 2016·29 cites·13 claims
- 0995US10894773B2Deuterated CFTR potentiatorsVERTEX PHARMACEUTICALS EUROPE LTD·Filed 2019·Granted Jan 19, 2021·6 cites·23 claims
- 1092US10759721B2Deuterated CFTR potentiatorsVERTEX PHARMACEUTICALS EUROPE LTD·Filed 2016·Granted Sep 1, 2020·5 cites·1 claims
- 1192US7901808B2System and method for sealing battery separatorCARDIAC PACEMAKERS INC·Filed 2005·Granted Mar 8, 2011·11 cites·33 claims
- 1290US10040748B24-hydroxybutyric acid analogsCONCERT PHARMACEUTICALS INC·Filed 2016·Granted Aug 7, 2018·6 cites·13 claims
- 1389US11708331B2Processes for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2018·Granted Jul 25, 2023·6 cites·9 claims
- 1488US12065395B2Processes for the preparation of deuterated D-serineSUN PHARMACEUTICAL IND INC·Filed 2020·Granted Aug 20, 2024·2 cites·21 claims
- 1587US2025025467A1Deuterated derivatives of ruxolitinibSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 1683US8377342B2Titanium suboxide powdersATRAVERDA LTD·Filed 2008·Granted Feb 19, 2013·7 cites·20 claims
- 1782US2023355629A1Deuterated derivatives of ruxolitinibSUN PHARMACEUTICAL IND INC·Filed 2022·Application pending·0 cites
- 1881US7718027B2Method and apparatus for concurrent welding and excise of battery separatorCARDIAC PACEMAKERS INC·Filed 2005·Granted May 18, 2010·4 cites·21 claims
- 1979US12473252B2Processes for the preparation of deuterated D-serineSUN PHARMACEUTICAL IND INC·Filed 2024·Granted Nov 18, 2025·0 cites·16 claims
- 2079US11170391B2Method and system for validating ensemble demand forecastsTARGET BRANDS INC·Filed 2018·Granted Nov 9, 2021·4 cites·20 claims
- 2179US8048252B2Method and apparatus for concurrent welding and excise of battery separatorCARDIAC PACEMAKERS INC·Filed 2010·Granted Nov 1, 2011·2 cites·20 claims
- 2276US9422295B2Deuterated ibrutinibCONCERT PHARMACEUTICALS INC·Filed 2013·Granted Aug 23, 2016·2 cites·9 claims
- 2374US11373199B2Method and system for generating ensemble demand forecastsTARGET BRANDS INC·Filed 2018·Granted Jun 28, 2022·2 cites·20 claims
- 2474US2021330674A1Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2574US2022041557A1Deuterated cftr potentiatorsVERTEX PHARMACEUTICALS EUROPE LTD·Filed 2020·Application pending·0 cites
- 2673US12024491B2Processes for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Granted Jul 2, 2024·0 cites·21 claims
- 2773US8551642B2System and method for sealing battery separatorMORGAN ADAM J·Filed 2011·Granted Oct 8, 2013·1 cites·20 claims
- 2872US2021403407A14-hydroxybutyric acid analogsCONCERT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2968US12002063B2Method and system for generating ensemble demand forecastsTARGET BRANDS INC·Filed 2022·Granted Jun 4, 2024·0 cites·20 claims
- 3068US2019308976A1Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3167US2019225605A1Deuterated palbociclibCONCERT PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3266US2015197525A1Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3366US2024300963A1Process for preparing enantiomerically enriched jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 3466US2017137383A1Deuterated cftr potentiatorsCONCERT PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3563US11295324B2Method and system for generating disaggregated demand forecasts from ensemble demand forecastsTARGET BRANDS INC·Filed 2018·Granted Apr 5, 2022·1 cites·15 claims
- 3663US2019100484A14-hydroxybutyric acid analogsCONCERT PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3762US2024307401A1Treatment of jak-inhibition-responsive disorders with prodrugs of jak inhibitorsSUN PHARMACEEUTICAL IND INC·Filed 2022·Application pending·0 cites
- 3862US2025361211A1Deuterated cftr potentiatorsVERTEX PHARMACEUTICALS EUROPE LTD·Filed 2024·Application pending·0 cites
- 3962US2017239254A1Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4060US2025264878A1Systems and methods for accurate indoor positioning in large scale facilitiesLUCI MOBILITY INC·Filed 2025·Application pending·0 cites
- 4158US2024368166A1Process for preparing enantiomerically enriched jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 4258US2016024084A1Deuterated palbociclibCONCERT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4356US2022213105A1Process for preparing enantiomerically enriched jak inhibitorsCONCERT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4455US12325707B2Process for preparing enantiomerically enriched JAK inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2020·Granted Jun 10, 2025·0 cites·19 claims
- 4554US2018051022A1Deuterated palbociclibCONCERT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4652US9777009B2Deuterated ibrutinibCONCERT PHARMACEUTICALS INC·Filed 2016·Granted Oct 3, 2017·0 cites·11 claims
- 4752US2015291618A1Carbamoylpyridone derivativesCONCERT PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4852US2024128323A1Metal oxide semiconductor field effect transistors (mosfet) including deep p-wells and methods of forming sameTHE RES FOUNDATION FOR THE STATE UNIVERSTIY OF NEW YORK·Filed 2022·Application pending·0 cites
- 4951US7037691B2Kinase mimic catalysts for asymmetric synthesis of phosphorylated inositols and cycloalkanolsTRUSTEES BOSTON COLLEGE·Filed 2002·Granted May 2, 2006·0 cites·17 claims
- 5050US2014363523A1Deuterated alpha-lipoic acidCONCERT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Adam J. Morgan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →